Please see below to view details for this session presenter

Andrew Strong

President and Chief Executive Officer, Kalon Biotherapeutics, LLC

Mr. Strong is the President and Chief Executive Officer of Kalon Biotherapeutics, LLC, a biologics development and manufacturing company formed by The Texas A&M University System in 2011.  Kalon seeks to accelerate drug development from the “bench to the patient” using the National Center for Therapeutics Manufacturing, a $50 million state of the art drug manufacturing platform.  Mr. Strong is responsible for all aspects of the business operations and has assembled an internationally renowned team of biomanufacturing professionals. Prior to joining Kalon, Mr. Strong served as the General Counsel and Compliance Officer for The Texas A&M University System from April 2009 through June 2011.  He also served as the General Counsel to the A&M System Board of Regents. Mr. Strong received a Bachelor of Science degree from Texas A&M University in Civil Engineering and is a registered professional engineer in Texas.  He also received a Doctorate of Jurisprudence from South Texas College of Law and is admitted to practice law in Texas and Louisiana.